LifeMD (LFMD) Stock Forecast & Price Target

LifeMD is a direct-to-patient healthcare company that offers virtual medical care and pharmacy services, with a focus on weight management. The company's recent acquisition of additional GLP-1 therapies and partnerships with major pharmaceutical companies position it well for future growth and profitability. The continued rise of telehealth and increasing consumer demand for convenient and affordable healthcare options also support a positive outlook for LifeMD. Key financial metrics such as increasing active subscribers and decreasing losses indicate that the company is on a path to financial strength and stability.

LifeMD is a direct-to-patient healthcare company that had a positive topline beat and high gross margin in 1Q26, but a bottom-line miss due to higher than expected net loss. Despite adding a significant number of telehealth subscribers and seeing impressive growth in signups and subscriber numbers for weight management and women's health, LifeMD's guidance for 2Q26 and FY2026 remained unchanged, showing lack of confidence in achieving significant revenue growth going forward. The company's reliance on recurring subscription revenue may not be sustainable in the long run, and the significant reduction in customer acquisition costs may not continue, putting a strain on profitability and cash flow.